logo-loader
viewOrgenesis

NA Proactive news snapshot: Mandalay Resources, Ideanomics, Aurania, Resources, Algernon Pharmaceuticals, GR Silver Mining, Metalla Royalty and Streaming UPDATE …

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires

Orgenesis - NA Proactive news snapshot: Orgenesis, Biocept, Champignon Brands, CytoDyn, Empower Clinics ...
Your daily round-up from the world of Proactive

GR Silver Mining Ltd (CVE:GSRL) (OTCQB:GLYXF) reported high grade silver intercepts as a result of recent drilling at its Plomosas silver project in Mexico. The results from the San Juan target area on the property include 3.5 metres at 1,419 grams per ton silver and 15.5 grams per ton gold, which represents 2,930 grams per ton silver equivalent. The intercept represents a new near-surface mineralized system sub-parallel to similar mineralization found as a result of sampling of the San Juan underground workings, which returned up to 6,128 grams per ton (g/t) silver over 0.2 metres.
It also confirmed that mineralization extended up to 300 metres down dip from the same recent samples at San Juan.

Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) said Monday it has received positive feedback from the US Food and Drug Administration regarding the company's plans to conduct a phase 2 COVID-19 clinical trial using its repurposed drug NP-120, known as Ifenprodil. Based on the feedback, the company said it plans to submit, as soon as possible, an investigational new drug (IND) application to the FDA to conduct a phase 2 clinical trial with Ifenprodil as a therapy for patients who experience respiratory complications as a result of contracting the coronavirus. "We are very pleased with the expedited response we received from the FDA on our pre-IND application," said CEO Christopher Moreau in a statement. "This is the first time Ifenprodil has been presented to the FDA in a formal process and their response was very encouraging."

Aurania Resources Ltd (CVE:ARU) (OTCMKTS:AUIAF) is well set up for the future according to analysts at Noble Capital Markets, who awarded the company an Outperfrom rating this week even as the junior exploration and mining sector grapples with the impact of the coronavirus (COVID-19). Aurania suspended its field operation and withdrew personnel from its flagship Cordillera de Cutucu operation located in the eastern foothills of the Andes mountain range in southeastern Ecuador. “While the stock has sold off with other junior explorers and the broader market, we think Aurania is likely in its strongest position yet to capture the value of its exploration activities,” Noble wrote.

Ideanomics Inc (NASDAQ:IDEX) will release its 2020 first-quarter financial results at about 4pm ET on May 11, followed by a conference call at 4:30 pm ET. Members of the company's senior management team will give prepared remarks, followed by a short question and answer session. Dial-in Number: (Toll-Free US & Canada): 877-407-3107 or 201-493-6796; for China: +86-400-120-2840. Ideanomics encourages investors and analysts to email their questions in advance of the webcast/call and time permitting management will take further questions during the live Q&A session. Please email [email protected]

Mandalay Resources Corporation (TSE:MND) (OTCQB:MNDJF) CEO Dominic Duffy said the miner is off to a strong start to 2020 thanks to “significant” production figures from its Australian and Swedish gold operations. The Toronto-based miner produced a consolidated 25,677 saleable ounces of gold equivalent in its first quarter, up from the 21,940 ounces produced during the same three-month period a year ago. Overall, the production increase was propelled by the high-grade Youle vein at Costerfield in Australia, which saw gold production lift by 36% and antimony increase by 62% compared to the most recent quarter.

Metalla Royalty and Streaming Ltd (CVE:MTA) (NYSEAMERICAN:MTA) CEO Brett Heath assured shareholders that the company was well-positioned to navigate the uncertainty caused by the coronavirus pandemic. The CEO’s comments came as the Vancouver-based streaming firm posted its third-quarter financial results highlighting a working capital balance of nearly C$6.7 million. "During these unparalleled times, we are monitoring our partners' operations closely,” Heath told shareholders in a statement. “With the majority of our royalties on projects in development being advanced by counterparties with strong balance sheets, we believe Metalla is well-positioned with a NAV heavy portfolio and strategy that allows for growth in volatile capital markets.”

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCQX:HERTF) subsidiary Voyage Cannabis Corp has been granted a cannabis oil sales license by Health Canada, allowing the company to begin sales of its award-winning, direct-to-vape, all-natural oil products. The company will sell those and other cannabis products to the provincial cannabis boards in Canada and directly to patients in the medical market as soon as possible. Going forward, the company intends to explore joint ventures with firms that have cannabis products that can be formulated at a Heritage facility and marketed to Canaidan consumers.

Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) announced that its pending acquisition Nextleaf Labs has signed a cannabis extraction agreement with an Atlantic Canada producer. The client, which Nextleaf called one of the early pioneers in legal cannabis production, will provide cannabis biomass that NextLeaf Labs will process into refined and distilled THC and CBD oils using its patented extraction and purification platform. Nextleaf Labs will retain a portion of the finished product and supply it to the wholesale market.

BioCorRx Inc (OTCQB:BICX) announced Friday that it is offering free access to its UnCraveRx app for weight loss management for a limited period to support people through the coronavirus (COVID-19) pandemic. In a statement, the Anaheim, California-based healthcare company which develops advanced treatment solutions for addiction, weight loss, and other related disorders, said people can download the company’s UnCraveRx App online at www.myuncraverx.com or through the Android or iOS app store. The app includes cardio, strength training, endurance fitness classes that cover a range of fitness styles, nutrition advice, and lifestyle support. BioCorRX said its app also offers tools to “track calorie intake and expenditure, overall physical activity, and distance tracking.”

Orgenesis Inc (NASDAQ:ORGS) has entered into an agreement to acquire the assets of Tamir Biotechnology Inc — including its broad-spectrum anti-viral platform ranpirnase. The acquisition will be completed for total stock and cash consideration valued at about $19 million based on the value of the stock at closing, according to a statement. Orgenesis said it plans to combine ranpirnase with its co-developed Bioxome technology for enhanced payload delivery directly to cells. 

Biocept Inc (NASDAQ: BIOC), a molecular diagnostics company, announced that it has verified a coronavirus (COVID-19) molecular diagnostic test, and plans to begin accepting physician-ordered testing requests for processing beginning on April 15. The San Diego company said that it has partnered with a national clinician network to accept patient samples and may obtain additional agreements as test capacity increased. Biocept operates a high-complexity, CLIA-certified, CAP-accredited and BSL-2 safety level laboratory in San Diego, with specialized, licensed molecular “lab staff that have been trained in performing the COVID-19 testing,” said the company. Biocept’s lab will be using ThermoFisher Scientific's TaqPath molecular diagnostic platform and kit which has received the US Food and Drug Administration’s Emergency Use Authorization (EUA).

Champignon Brands Inc (CSE:SHRM) (OTCMKTS:SHRMF) inked a transformative acquisition that will position the company as a leader in the burgeoning psychedelics space.
The Vancouver-based company announced its plans to acquire ketamine clinic operator AltMed Capital Corp in an all-share deal that will see the two companies launch a network of subspecialty therapeutic clinics across the US. The deal also gives Champignon a suite of intellectual property and research and development initiatives boosted by AltMed’s founder and CEO Dr Roger McIntyre, a widely recognized expert in the study and treatment of mood disorders.

CytoDyn Inc (OTCQB:CYDY), which has been utilizing its flagship drug candidate leronlimab as a treatment for the coronavirus (COVID-19), told investors Monday that the first five patients with mild-to-moderate symptoms given the drug were able to be taken off oxygen after treatment. So far, the company has treated more than 30 patients at four hospitals and clinics with authorization from the US Food and Drug Administration under Emergency Investigational New Drug applications. CytoDyn also announced the appointment of Chairman Scott Kelly as chief medical officer and head of business development. Kelly has served as a director since 2017 and chairman since December 2018, a position he will retain.

Empower Clinics Inc (CSE:CBDT) (OTCMKTS:EPWCF), through its Sun Valley Health division, announced Monday that it has launched telemedicine services for patients. With its base of 165,000 patients, the company said it will begin offering digital access to physicians, using the newly launched telemedicine platform, for a variety of consultations. Patients can use it both in-clinics and virtually through secure video, on a browser, and in a mobile app. "The COVID-19 pandemic has forever changed the interaction between physicians and patients, requiring immediate advancement in technology solutions, that offer safe interactions to a vast array of patient needs." said CEO Steven McAuley in a statement.

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCMKTS:HERTF) has announced that the annual general and special meeting of shareholders initially scheduled for April 16 at 1 pm EST at the Yorkville Conference Centre in Toronto has been adjourned to May 15, 2020 at 1 pm EST, It will be held virtually in response to the coronavirus (COVID-19) health threat. All participants will be required to register online prior to the Special Meeting. Registration will be available online starting 8 am EST May 8 to 12:30 pm EST May 15.

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), a developer of pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced that CEO Armando Anidowill present a company overview at the 19th annual Needham Virtual Healthcare Conference. The presentation will be conducted virtually at 2:50 pm ET on April 15, and a live webcast of the presentation will be available on the investor relations page of zynerba.com.

Auryn Resources Inc (TSE:AUG) (NYSEAMERICAN:AUG) has announced that its annual general meeting, originally scheduled for June 4, has been cancelled and will be rescheduled at a later date. The decision to postpone was made in light of ongoing concerns related to the spread of coronavirus (COVID-19) and to mitigate potential risks to the health and safety of its shareholders and employees. Once the company's board of directors has set a new meeting date, Auryn will set the new record date for the meeting and will file an amended notice of meeting.

Gevo Inc (NASDAQ:GEVO) announced Monday that CEO Patrick Gruber will participate and present in the alphaDIRECT Advisors Virtual Conference Series on April 14 at 12:00 pm ET as part of the alphaDIRECT Investor Intelligence Program. Gruber will present on Gevo’s Low Carbon, Clean Fuels followed by a question and answer session. The presentation will be webcast live and available for replay under the Investor Relations page found on www.gevo.com and under alphaDIRECT Advisors center page at www.alphadirectadvisors.com. Investors and other persons interested in participating in the event must register at: https://globalmeet.webcasts.com/starthere.jsp?ei=1304371&tp_key=9b5624f4c0. Please note that registration for the live event is limited but may be accessed at any time for replay after the presentation ends.

Quick facts: Orgenesis

Price: 5.56 USD

NASDAQ:ORGS
Market: NASDAQ
Market Cap: $122.3 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Orgenesis named herein, including the promotion by the Company of Orgenesis in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Orgenesis signs deal with Accellix, invites Academy Award...

Orgenesis (NASDAQ: ORGS) President and CEO Vered Caplan joined Steve Darling from our Proactive New York studio to discuss the company signing an important co-development deal with Accellix. That company specializes in assay migration and delivery platforms for on-demand process...

on 4/11/19

10 min read